That is, compared to insulin, 57 and 30 patients would need to be treated with a GLP-1RA for a mean of 2.3 years to prevent one case of all-cause mortality and hospitalized hypoglycemia, respectively, which would cost US$54,851 and US$29,115 per case of all-cause mortality and hospitalized hypoglycemia prevented, respectively, from the payer perspective, and would save US$19,391 and US$10,293, respectively, from the healthcare sector perspective
More packs and other packing sizes are available
Understanding the root cause of the disease is critical to achieving optimal wellness
Pulmonary Aspiration During General Anesthesia or Deep Sedation Inform patients that SOLIQUA 100/33 may cause their stomach to empty more slowly which may lead to complications with anesthesia or deep sedation during planned surgeries or procedures
As many as 65% exceed safe endotoxin thresholds that can cause inflammatory reactions